Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Orphai Therapeutics

Clinical trials sponsored by Orphai Therapeutics, explained in plain language.

Not yet finished but already full! 1

New inhaled drug shows promise for tough lung and heart condition

Disease control Ongoing

This study tests an inhaled medication called LAM-001 (sirolimus) in 85 adults with pulmonary hypertension caused by interstitial lung disease. The goal is to see if it improves blood flow in the lungs and is safe to use alongside standard treatments. Participants are randomly as…

Phase: PHASE2 • Sponsor: OrphAI Therapeutics • Aim: Disease control

Last updated May 26, 2026 12:00 UTC